According to Zacks, “Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels. “
Gevo (NASDAQ:GEVO) opened at 0.4757 on Friday. The stock’s 50 day moving average price is $0.55 and its 200-day moving average price is $0.45. Gevo has a one year low of $0.22 and a one year high of $2.24. The firm’s market capitalization is $23.35 million.
Gevo (NASDAQ:GEVO) last announced its earnings results on Tuesday, August 9th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.27) by $0.12. Gevo had a negative return on equity of 67.50% and a negative net margin of 133.03%. The business had revenue of $8.11 million for the quarter, compared to analyst estimates of $8.90 million. On average, equities research analysts expect that Gevo will post ($0.72) EPS for the current fiscal year.
An institutional investor recently raised its position in Gevo stock. Vanguard Group Inc. boosted its position in shares of Gevo Inc. (NASDAQ:GEVO) by 357.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 815,973 shares of the company’s stock after buying an additional 637,440 shares during the period. Vanguard Group Inc. owned 3.55% of Gevo worth $481,000 as of its most recent filing with the SEC. 3.50% of the stock is currently owned by institutional investors.
Gevo Company Profile
Gevo, Inc (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Gevo Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo Inc. and related companies with MarketBeat.com's FREE daily email newsletter.